Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03974152 · ClinicalTrials.gov registry record · NA
Effects of Nicotine Salt Aerosol on Cigarette Smokers
A NA study, sponsored by Eastern Virginia Medical School.
- Terminated
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT03974152: Clinical Trial NA study, sponsored by Eastern Virginia Medical School.
NCT03974152 is a NA study that was terminated before completion, run by Eastern Virginia Medical School. The registered enrollment target is 11 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03974152, a NA study, was terminated before completion, sponsored by Eastern Virginia Medical School.
- TERMINATED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
This grant compares the effects of cigarette smoking, protonated nicotine ("salt") aerosol through an Electronic Nicotine Delivery System (ENDS), and unprotonated nicotine aerosol through an ENDS on nicotine delivery, nicotine craving, and other outcomes in cigarette smokers.
Primary Outcome
Change in plasma nicotine level
Interventions
- OTHER Subox Mini C with Avail 18 mg nicotine salt (protonated)
- OTHER Subox Mini C with Avail 18 mg nicotine (unprotonated)
- OTHER Own brand cigarette
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2019-06-10 |
| Est. Completion | 2020-03-05 |
| Phase | NA |
Why NCT03974152 stopped before completion
NCT03974152 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Subox Mini C with Avail 18 mg nicotine salt (protonated) is the first listed.
NCT03974152 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03974152 about?
NCT03974152 is a clinical study titled "Effects of Nicotine Salt Aerosol on Cigarette Smokers". This grant compares the effects of cigarette smoking, protonated nicotine ("salt") aerosol through an Electronic Nicotine Delivery System (ENDS), and unprotonated nicotine aerosol through an ENDS on nicotine delivery, nicotine craving, and other outcomes in cigarette smokers.
What is the current status of trial NCT03974152?
This trial is currently terminated. It is a NA study. The enrollment target is 11 participants. The study started on 2019-06-10. Estimated completion is 2020-03-05.
What interventions are being tested in trial NCT03974152?
The interventions under investigation include: Subox Mini C with Avail 18 mg nicotine salt (protonated) (OTHER), Subox Mini C with Avail 18 mg nicotine (unprotonated) (OTHER), Own brand cigarette (OTHER).
Who is sponsoring clinical trial NCT03974152?
This trial is sponsored by Eastern Virginia Medical School, which has 36 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03974152's enrollment target sits among peer trials
11 1927th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI